학술논문
Target wise and pound foolish: A simple technique to evaluate the trade-off between clinical benefit and economic burden of monoclonal antibodies
Document Type
Article
Author
Source
In Journal of Cancer Policy December 2018 18:11-19
Subject
Language
ISSN
2213-5383